Latest News

Logistics giant DHL announced a strategic investment of €2 billion over the next five years to enhance its life sciences and healthcare logistics operations worldwide. As part of its Strategy 2030 roadmap, the company plans to expand and upgrade infrastructure for medical supply chains across the Americas, Europe, the Middle East and Asia-Pacific. This includes building new temperature-controlled warehouses, bolstering cold chain capabilities for pharmaceuticals, and improving last-mile delivery networks for hospitals and clinics. About half of the investment is earmarked for the Americas, with roughly 25% each for Asia-Pacific and the EMEA region. DHL will establish major new pharma-logistics facilities, such as dedicated healthcare distribution centers in markets like Singapore, Malaysia, and South Korea. The initiative also introduces a unified DHL Health Logistics division to offer clients end-to-end visibility and compliance across borders. By 2030, the company expects these investments to significantly boost its capacity to handle vaccines, clinical trial materials, and other critical medical products, thereby improving the resilience of global healthcare supply chains.

Elmotaz for Imports and Exports has launched a new line of surgical disposable products, expanding its portfolio beyond its core offerings in needles and syringes. The newly introduced line includes advanced wound dressings, surgical drapes, and procedure kits, catering to the needs of operating rooms and emergency care. This launch comes in response to feedback from healthcare clients seeking a more comprehensive one-stop source for high-quality medical consumables. With the addition of these products, Elmotaz continues to grow its market presence in Egypt’s medical sector. Early client response has been positive, as hospitals appreciate the convenience of procuring a wider range of supplies through a trusted distributor. The company expects the surgical supplies line to contribute significantly to its 2025 sales and strengthen relationships with key healthcare providers. This strategic broadening of the product base aligns with Elmotaz’s mission to support medical professionals with reliable, world-class supplies.

Elmotaz for Imports and Exports is contributing to Egypt’s national ‘Decent Life’ initiative by providing essential medical supplies to underserved rural clinics. In a new public-private collaboration with the Ministry of Health, Elmotaz will distribute equipment such as syringes, IV kits, and basic diagnostic tools to healthcare units in remote villages. The goal is to help upgrade medical services in these areas, ensuring that residents have better access to quality care as the government renovates and expands rural health infrastructure. Company officials stated that participating in the Decent Life (Hayah Karima) project aligns with Elmotaz’s commitment to social responsibility and improving healthcare outcomes. By leveraging its logistics network, the company can efficiently deliver necessary supplies to dozens of clinics that were previously hard to reach. This effort not only supports community health needs but also demonstrates how Egypt’s private sector can play a vital role in national health initiatives. Elmotaz’s involvement is expected to benefit thousands of patients in rural communities and contribute to the overall success of the program.

The fight against polio saw significant progress in 2024, with Africa maintaining its wild polio-free status for a third consecutive year and cases reaching historic lows globally. Health officials across the African continent continued robust vaccination campaigns to prevent any resurgence of wild poliovirus, following its declared elimination in the region in 2020. While no wild polio cases have been detected in Africa since then, some countries did respond to isolated outbreaks of vaccine-derived polio strains with targeted immunization drives, which were largely successful in containing those incidents. Meanwhile, in the last two countries where wild polio remains endemic — Pakistan and Afghanistan — the number of recorded cases dropped significantly compared to previous years, thanks to intensified vaccination and security efforts. International health agencies, including WHO and UNICEF, are cautiously optimistic that eradication of the wild virus is within reach if current efforts persist. They stress that maintaining high vaccination coverage everywhere is crucial until polio is completely eradicated. The overall milestone of a polio-free Africa and the decline in cases elsewhere demonstrate tangible headway in the decades-long global eradication campaign.

Robotic-assisted surgery is becoming more prevalent as hospitals around the world invest in advanced surgical robot systems to improve patient outcomes. In 2024, several major medical centers in emerging markets, including the Middle East and Asia, acquired surgical robots for procedures ranging from orthopedics to cardiology. These systems allow surgeons to perform minimally invasive operations with greater precision, using robotic arms that translate the surgeon’s hand motions into smaller, exact movements inside the patient’s body. The trend, once limited largely to the US and Europe, is now global as competition among medical device companies drives down costs and training programs for surgeons expand. Countries like India, Saudi Arabia, and Brazil have reported their first successful complex surgeries performed with robotic assistance in the last couple of years. Patients often experience shorter hospital stays and reduced recovery times with robotic surgery due to smaller incisions and lower risk of complications. Experts predict that as the technology becomes more accessible, surgical robots will become standard equipment in many operating theaters, ushering in a new era of high-tech surgical care.

Artificial Intelligence (AI) is playing an expanding role in healthcare, from assisting in medical diagnoses to optimizing hospital operations. In 2024, more hospitals and clinics adopted AI-powered software to help interpret medical images such as X-rays and MRIs with greater speed and accuracy, aiding doctors in detecting conditions like cancers and fractures earlier. AI-driven diagnostic tools for analyzing lab results and patient data have also become more common, offering decision support to clinicians and helping predict patient risks based on large data patterns. Beyond diagnostics, healthcare logistics and administrative tasks are benefiting from AI as well. Machine learning algorithms are being used to forecast inventory needs for medicines and supplies, improving supply chain efficiency and reducing shortages. Some health systems have implemented AI chatbots to triage patients’ symptoms online before they see a doctor, streamlining the patient flow. Despite these advancements, experts caution that AI systems must be rigorously validated and monitored to ensure they are accurate and unbiased. Nonetheless, the momentum in 2024 indicates that AI will continue to integrate into various aspects of healthcare, promising improvements in both patient outcomes and operational efficiency.

Elmotaz for Imports and Exports has inaugurated a new state-of-the-art distribution center to enhance its medical supply chain capacity. The facility, located in greater Cairo, spans 5,000 square meters and is equipped with advanced inventory management systems, including climate-controlled storage for sensitive medical products. The expansion is designed to accommodate the company’s rapid growth and to ensure faster, more efficient delivery of medical supplies to hospitals and pharmacies across Egypt. By opening this logistics hub, Elmotaz aims to streamline order fulfillment and reduce transit times, especially for clients in remote regions. The center’s modern infrastructure allows for larger stock volumes and better quality control, which is crucial as demand for imported medical devices and consumables continues to rise. Company leadership highlighted that this investment in infrastructure is part of a broader strategic plan to bolster supply reliability and customer service, reinforcing Elmotaz’s position in the healthcare distribution sector.

A recent industry report projects that India’s pharmaceutical exports will nearly double by 2030, solidifying the country’s position as a global medicine supplier. In 2023, India’s pharma export value was around $27 billion, and it is expected to reach approximately $60–65 billion by the end of the decade. This growth is driven by expansions in generic drug manufacturing, vaccines, and medical device production, as well as government initiatives to incentivize pharma innovation and streamline regulations. India is already the world’s largest provider of generic medicines and a major source of vaccines for developing countries. The anticipated surge in exports will come from scaling up production capacity and entering new markets in Africa, Asia, and Latin America. Indian companies are also investing in higher-value research and biosimilars to diversify their portfolio. Analysts note that if quality and supply reliability are maintained, India’s rise can help stabilize global medicine supply chains, especially as nations seek to reduce over-reliance on any single source for critical health commodities.

Egypt has entered the next phase of its Universal Health Insurance (UHI) program, extending coverage to additional governorates as part of a nationwide healthcare reform. In 2024, authorities rolled out UHI services to five more regions, aiming to provide affordable, comprehensive healthcare access to millions more Egyptians. The UHI system, which launched in 2019 and is planned to reach all provinces by 2032, establishes a mandatory health coverage model that reduces out-of-pocket costs and improves service quality in public hospitals. With this expansion, the government projects the number of citizens benefiting from health insurance will rise significantly. According to the Health Ministry, insured beneficiaries are expected to reach roughly 69 million people — a substantial increase compared to a decade ago. Implementation has included upgrading healthcare facilities, integrating digital health records, and contracting private providers to ensure adequate service capacity. Officials say the phased approach has allowed for refining the system, and the latest rollout builds on lessons learned to further strengthen healthcare delivery and equity under the UHI scheme.

Innovative drone delivery services are increasingly being used to transport medical supplies to remote and hard-to-reach areas around the world. In Africa, countries like Rwanda and Ghana have established drone networks that deliver blood products, vaccines, and medications to rural clinics within minutes, overcoming challenges of poor road infrastructure. These services, operated by specialized companies in partnership with health ministries, have sharply reduced delivery times for urgent supplies — in some cases from several hours down to 30 minutes or less. The success of drones in African healthcare logistics is inspiring similar efforts elsewhere. In Asia and Latin America, pilot programs are testing drones for delivering medicines to islands and mountainous regions. Even in urban settings or large hospital systems, drones are being explored to move lab samples and medical products faster than ground transport can. Regulators are gradually developing guidelines to ensure safety and privacy, as the technology proves its value. As drone fleets scale up, many experts predict they will become a regular component of health supply chains, improving emergency response and routine deliveries alike.

Egypt hosted the Africa Health ExCon in Cairo, a major annual healthcare exhibition and conference aimed at positioning Africa as a hub for health innovation and trade. The 2024 event brought together thousands of participants, including medical equipment manufacturers, pharmaceutical companies, healthcare providers, and government officials from across the continent and beyond. Over several days, exhibitors showcased the latest medical technologies and services, from diagnostic devices and telemedicine solutions to hospital infrastructure and pharmaceuticals tailored for African markets. The conference also featured high-level discussions on improving healthcare in Africa, with topics such as supply chain resilience, local production of medicines, and public-private partnerships in healthcare delivery. Several cooperation agreements and memoranda of understanding were signed during the event, including deals for joint ventures to produce medical supplies locally and initiatives to train healthcare workers. Organizers from Egypt’s Unified Procurement Authority highlighted that Africa Health ExCon has become a key platform for networking and knowledge exchange. The outcomes from the 2024 gathering are expected to advance the continent’s collective efforts in achieving more accessible, high-quality healthcare.

The adoption of telehealth has continued to grow even as the COVID-19 pandemic wanes, becoming a permanent feature of healthcare delivery in many regions. In developing and developed countries alike, hospitals and clinics are investing in telemedicine platforms to reach patients who have difficulty accessing in-person care. Patients can now consult with doctors via secure video calls, use mobile health apps for follow-up monitoring, and receive remote diagnoses for many common conditions, significantly expanding access to care in rural or underserved communities. Governments and insurers have taken steps to integrate telehealth into standard healthcare systems. Many countries have updated regulations to allow teleconsultations and reimburse virtual visits similarly to traditional appointments. The Middle East and Africa have seen a surge of digital health startups offering services ranging from mental health counseling online to AI-powered remote triage. While challenges such as internet connectivity and ensuring quality of care remain, the overall trend points to hybrid healthcare models. Industry experts say telehealth not only increases convenience for patients but also eases burdens on healthcare facilities by handling minor ailments and routine check-ups remotely.